drugset / Trial / NCT02144259
The Impact of Contraception on Postpartum Weight Loss
RandomizedParallel-groupOpen-labelBasic science
Summary
This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a series of questions, take a pregnancy test, and be weighed. Total length of participation for each subject is 1 year or until pregnancy.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etonogestrel | Unknown | 68 mg | Other |
| Comparator | medroxyprogesterone acetate | Other / unclassified | 150 mg | Intramuscular |
Indications
No indication recorded.